MME advises Northpond Ventures, a US VC with the approach to build and support breakthrough science and technology driven businesses to create a marked impact on humanity, as lead investor in connection with a USD 12.7m seed financing round into Molecule AG.
Molecule is a decentralized biotech protocol, building a web3 marketplace for research-related IP. Its platform and scalable framework for biotech DAOs connects academics and biotech companies with quick and easy funding, while enabling patient, researcher, and investor communities to directly govern and own research-related IP.
The MME team advising Northpond Ventures includes Alex Enzler (Partner, Corporate/M&A, Lead), Michael Kunz (Senior Associate, Blockchain/DLT) and Martina Kim (Associate, Corporate/M&A). Cooley LLP with Alfred Brown (Partner), Connor Tweardy (Associate) and Ryan Sonberg (Associate) acted as US lead counsel to Northpond Ventures.
